Log in to save to my catalogue

Xolair® (omalizumab) enrollment in a tertiary care allergy and asthma clinic in Canada

Xolair® (omalizumab) enrollment in a tertiary care allergy and asthma clinic in Canada

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4304125

Xolair® (omalizumab) enrollment in a tertiary care allergy and asthma clinic in Canada

About this item

Full title

Xolair® (omalizumab) enrollment in a tertiary care allergy and asthma clinic in Canada

Publisher

BioMed Central Ltd

Journal title

Allergy, asthma, and clinical immunology, 2014-12, Vol.10 (S2), p.A5-A5, Article A5

Language

English

Formats

Publication information

Publisher

BioMed Central Ltd

Subjects

Subjects and topics

More information

Alternative Titles

Full title

Xolair® (omalizumab) enrollment in a tertiary care allergy and asthma clinic in Canada

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4304125

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4304125

Other Identifiers

ISSN

1710-1492,1710-1484

E-ISSN

1710-1492

DOI

10.1186/1710-1492-10-S2-A5

How to access this item